$0.6301
0.0001000.02%
Pre-Market: Jan 21, 6:31 AM EDT
VolitionRX reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of VolitionRX using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-0.07 | $-0.07 | 0.00 % |
Q2 | 2024-08-14 | $-0.08 | $-0.09 | 11.1 % |
Q1 | 2024-05-13 | $-0.10 | $-0.11 | 9.09 % |
Q4 | 2024-03-25 | $-0.11 | $-0.11 | 0.00 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $474.52K | $652.00K | -27.2 % |
Q2 | 2024-08-14 | $395.80K | $480.00K | -17.5 % |
Q1 | 2024-05-13 | $171.54K | $390.00K | -56.0 % |
Q4 | 2024-03-25 | $243.97K | $450.00K | -45.8 % |
VolitionRX (VNRX) is scheduled to report earnings on March 24, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.07, which hit the estimate of $-0.07.
The Actual Revenue was $474.5K, which missed the estimate of $652K.
Browse earnings estimates, EPS, and revenue on all stocks.